Skip to content

Efficacy of Cognitive Behavior Therapy in the Treatment of Chronic Pelvic Pain in Women

Efficacy of Cognitive Behavior Therapy in the Treatment of Chronic Pelvic Pain in Women: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06445790
Enrollment
60
Registered
2024-06-06
Start date
2024-06-20
Completion date
2024-10-20
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain Syndrome

Keywords

Chronic Pelvic Pain, Pelvic Pain, Women

Brief summary

This will be the pilot study trial. The target population will be 30 individuals with Chronic Pelvic Pain (CCP). There will be 02 groups, Experimental Group and Control Group. The primary outcome measure will be Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ). The experimental group will receive CBT spread over 12 sessions.

Interventions

BEHAVIORALCognitive Behavior Therapy for Chronic Pelvic Pain-CBT-cp

CBT-cp will be administered weekly sessions for 12 weeks.

Sponsors

Islamia University of Bahawalpur
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Women of reproductive age. 2. Women with Chronic Pelvic Pain having no pathological or anatomical causes. 3. Women with Overactive Bladder Syndrome. 4. Women with Vulvodynia. -

Exclusion criteria

1. Women experiencing perimenopause or menopause. 2. Women with medical, or gynecological or hormonal abnormalities. 3. Women with mental disorders. 4. Women who use substances. -

Design outcomes

Primary

MeasureTime frameDescription
Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ)Up to 16 weeksImpact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026